HEATR5B
geneOn this page
Also known as KIAA1414DKFZp686P15184p200p200a
Summary
HEATR5B (HEAT repeat containing 5B, HGNC:29273) is a protein-coding gene on chromosome 2p22.2, encoding HEAT repeat-containing protein 5B (Q9P2D3). Component of clathrin-coated vesicles.
Predicted to be involved in endocytosis; protein localization; and retrograde transport, endosome to Golgi. Located in Golgi apparatus; cytosol; and nucleoplasm.
Source: NCBI Gene 54497 — RefSeq curated summary.
At a glance
- Gene–disease (curated): pontocerebellar hypoplasia (Moderate, GenCC)
- GWAS associations: 12
- Clinical variants (ClinVar): 295 total — 3 likely-pathogenic
- MANE Select transcript:
NM_019024
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29273 |
| Approved symbol | HEATR5B |
| Name | HEAT repeat containing 5B |
| Location | 2p22.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1414, DKFZp686P15184, p200, p200a |
| Ensembl gene | ENSG00000008869 |
| Ensembl biotype | protein_coding |
| OMIM | 619627 |
| Entrez | 54497 |
Gene structure
Transcript identifiers
Ensembl transcripts: 18 — 15 protein_coding, 3 retained_intron
ENST00000233099, ENST00000425467, ENST00000467978, ENST00000471051, ENST00000478810, ENST00000903977, ENST00000903978, ENST00000903979, ENST00000903980, ENST00000903981, ENST00000903982, ENST00000920713, ENST00000920714, ENST00000920715, ENST00000920716, ENST00000920717, ENST00000920718, ENST00000950344
RefSeq mRNA: 1 — MANE Select: NM_019024
NM_019024
CCDS: CCDS33181
Canonical transcript exons
ENST00000233099 — 36 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000397453 | 37005632 | 37005759 |
| ENSE00000397456 | 37000586 | 37000813 |
| ENSE00000747126 | 37002306 | 37002572 |
| ENSE00000809598 | 36988646 | 36988859 |
| ENSE00000809599 | 36990648 | 36990799 |
| ENSE00000809601 | 37003542 | 37003686 |
| ENSE00000809603 | 37007050 | 37007304 |
| ENSE00000809604 | 37008611 | 37008848 |
| ENSE00001404475 | 37084269 | 37084372 |
| ENSE00001599689 | 37076911 | 37077019 |
| ENSE00001607869 | 37020655 | 37020836 |
| ENSE00001626463 | 37058451 | 37058560 |
| ENSE00001626844 | 37060581 | 37060733 |
| ENSE00001634083 | 37028681 | 37028920 |
| ENSE00001641482 | 37075485 | 37075634 |
| ENSE00001651969 | 37064740 | 37064990 |
| ENSE00001653294 | 37013841 | 37014020 |
| ENSE00001654688 | 37072110 | 37072281 |
| ENSE00001674415 | 37057317 | 37057480 |
| ENSE00001690150 | 37037855 | 37038024 |
| ENSE00001693452 | 37068681 | 37068930 |
| ENSE00001697720 | 37070230 | 37070387 |
| ENSE00001700498 | 37027923 | 37028174 |
| ENSE00001716222 | 37040329 | 37040518 |
| ENSE00001720462 | 37019809 | 37019877 |
| ENSE00001729909 | 37061939 | 37062050 |
| ENSE00001748954 | 37065755 | 37065910 |
| ENSE00001756563 | 37056440 | 37056615 |
| ENSE00001766248 | 37058888 | 37058987 |
| ENSE00001775312 | 37079120 | 37079331 |
| ENSE00001796044 | 37041133 | 37041292 |
| ENSE00001796147 | 37083289 | 37083436 |
| ENSE00001799079 | 37032629 | 37032773 |
| ENSE00001923918 | 36980895 | 36981794 |
| ENSE00003488669 | 37049653 | 37049843 |
| ENSE00003603864 | 37053502 | 37053607 |
Expression profiles
Bgee: expression breadth ubiquitous, 261 present calls, max score 97.21.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 13.4821 / max 229.6578, expressed in 1771 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 27759 | 11.4148 | 1763 |
| 27758 | 1.5101 | 620 |
| 27757 | 0.5483 | 267 |
| 27760 | 0.0090 | 3 |
Top tissues by expression
261 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left ventricle myocardium | UBERON:0006566 | 97.21 | gold quality |
| oviduct epithelium | UBERON:0004804 | 95.24 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 94.30 | gold quality |
| ileal mucosa | UBERON:0000331 | 93.30 | gold quality |
| myocardium | UBERON:0002349 | 93.04 | gold quality |
| upper arm skin | UBERON:0004263 | 92.46 | gold quality |
| heart right ventricle | UBERON:0002080 | 91.53 | gold quality |
| cortical plate | UBERON:0005343 | 89.51 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 89.00 | silver quality |
| calcaneal tendon | UBERON:0003701 | 88.59 | gold quality |
| cerebellar vermis | UBERON:0004720 | 88.44 | gold quality |
| body of pancreas | UBERON:0001150 | 88.43 | gold quality |
| tibia | UBERON:0000979 | 88.37 | gold quality |
| upper leg skin | UBERON:0004262 | 88.16 | gold quality |
| skin of hip | UBERON:0001554 | 88.15 | gold quality |
| thymus | UBERON:0002370 | 88.06 | gold quality |
| bone marrow cell | CL:0002092 | 88.03 | gold quality |
| bronchial epithelial cell | CL:0002328 | 87.91 | gold quality |
| bronchus | UBERON:0002185 | 87.62 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.04 | gold quality |
| tonsil | UBERON:0002372 | 87.03 | gold quality |
| pancreas | UBERON:0001264 | 86.74 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 86.61 | gold quality |
| jejunal mucosa | UBERON:0000399 | 86.24 | gold quality |
| pancreatic ductal cell | CL:0002079 | 86.19 | silver quality |
| seminal vesicle | UBERON:0000998 | 86.19 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 86.19 | gold quality |
| nasopharynx | UBERON:0001728 | 86.17 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 86.16 | gold quality |
| superficial temporal artery | UBERON:0001614 | 86.01 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.05 |
| E-MTAB-7606 | no | 2569.38 |
| E-MTAB-6058 | no | 284.21 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
43 targeting HEATR5B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-499A-5P | 99.98 | 70.79 | 1323 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-381-3P | 99.93 | 71.87 | 2854 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-1-3P | 99.93 | 72.35 | 1914 |
| HSA-MIR-206 | 99.93 | 72.50 | 1893 |
| HSA-MIR-300 | 99.92 | 71.76 | 2856 |
| HSA-MIR-613 | 99.91 | 71.50 | 1710 |
| HSA-MIR-369-3P | 99.85 | 70.52 | 2264 |
| HSA-MIR-6079 | 99.84 | 68.54 | 1170 |
| HSA-MIR-7154-5P | 99.69 | 70.52 | 1900 |
| HSA-MIR-24-3P | 99.59 | 69.97 | 1934 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-671-5P | 99.52 | 67.11 | 1277 |
| HSA-MIR-4489 | 99.50 | 65.56 | 785 |
| HSA-MIR-766-5P | 99.47 | 67.91 | 2225 |
| HSA-MIR-7849-3P | 99.47 | 68.17 | 1224 |
| HSA-MIR-6828-5P | 99.31 | 69.21 | 1433 |
Literature-anchored findings (GeneRIF, showing 2)
- Biallelic hypomorphic mutations in HEATR5B, encoding HEAT repeat-containing protein 5B, in a neurological syndrome with pontocerebellar hypoplasia. (PMID:33824466)
- Fast-evolving cofactors regulate the role of HEATR5 complexes in intra-Golgi trafficking. (PMID:38240799)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | heatr5b | ENSDARG00000059116 |
| mus_musculus | Heatr5b | ENSMUSG00000039414 |
| rattus_norvegicus | Heatr5b | ENSRNOG00000025926 |
| drosophila_melanogaster | CG2747 | FBGN0037541 |
| caenorhabditis_elegans | WBGENE00015743 |
Paralogs (1): HEATR5A (ENSG00000129493)
Protein
Protein identifiers
HEAT repeat-containing protein 5B — Q9P2D3 (reviewed: Q9P2D3)
All UniProt accessions (2): Q9P2D3, H7C2X3
UniProt curated annotations — full annotation on UniProt →
Function. Component of clathrin-coated vesicles. Component of the aftiphilin/p200/gamma-synergin complex, which plays roles in AP1G1/AP-1-mediated protein trafficking including the trafficking of transferrin from early to recycling endosomes, and the membrane trafficking of furin and the lysosomal enzyme cathepsin D between the trans-Golgi network (TGN) and endosomes.
Subunit / interactions. Self-associates. Component of the aftiphilin/p200/gamma-synergin complex, at least composed of AFTPH/aftiphilin, HEATR5B/p200a and SYNRG/gamma-synergin, which plays a role in the AP1G1/AP-1-mediated protein trafficking from early to recycling endosomes and between the trans-Golgi network (TGN) and endosomes. Within the complex interacts with AFTPH/aftiphilin and SYNRG/gamma-synergin; the interactions are direct. Interacts with GGA1.
Subcellular location. Cytoplasm. Perinuclear region. Cytoplasmic vesicle. Clathrin-coated vesicle.
Similarity. Belongs to the HEATR5 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9P2D3-1 | 1 | yes |
| Q9P2D3-2 | 2 | |
| Q9P2D3-3 | 3 |
RefSeq proteins (1): NP_061897* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011989 | ARM-like | Homologous_superfamily |
| IPR016024 | ARM-type_fold | Homologous_superfamily |
| IPR040108 | Laa1/Sip1/HEATR5 | Family |
| IPR046837 | Laa1/Sip1/HEATR5-like_HEAT | Repeat |
Pfam: PF20210, PF25468
UniProt features (14 total): modified residue 4, repeat 3, splice variant 3, sequence conflict 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9P2D3-F1 | 81.47 | 0.35 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (4): 1123, 1563, 1564, 1737
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 81 (showing top):
GCM_ZNF198, GOBP_VESICLE_MEDIATED_TRANSPORT, GOCC_COATED_VESICLE, GOBP_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI, CUI_TCF21_TARGETS_2_DN, GOBP_IMPORT_INTO_CELL, GOBP_ENDOCYTOSIS, GOCC_CLATHRIN_COATED_VESICLE, GOBP_CYTOSOLIC_TRANSPORT, GOCC_ENDOCYTIC_VESICLE, chr2p22, GOBP_ENDOSOMAL_TRANSPORT, GOBP_INTRACELLULAR_TRANSPORT, HES4_TARGET_GENES, HHEX_TARGET_GENES
GO Biological Process (4): endocytosis (GO:0006897), intracellular protein localization (GO:0008104), protein transport (GO:0015031), retrograde transport, endosome to Golgi (GO:0042147)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (9): nucleoplasm (GO:0005654), Golgi apparatus (GO:0005794), cytosol (GO:0005829), membrane (GO:0016020), clathrin-coated vesicle (GO:0030136), endocytic vesicle (GO:0030139), perinuclear region of cytoplasm (GO:0048471), cytoplasm (GO:0005737), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 5 |
| cytoplasm | 4 |
| vesicle budding from membrane | 1 |
| membrane invagination | 1 |
| vesicle-mediated transport | 1 |
| import into cell | 1 |
| macromolecule localization | 1 |
| transport | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| intercellular transport | 1 |
| endosomal transport | 1 |
| cytosolic transport | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| coated vesicle | 1 |
| cytoplasmic vesicle | 1 |
| intracellular anatomical structure | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
766 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HEATR5B | SLC67A1-AS | Q8N1D0 | 473 |
| HEATR5B | GLYATL3 | Q5SZD4 | 453 |
| HEATR5B | FAM174A | Q8TBP5 | 452 |
| HEATR5B | VSIG10 | Q8N0Z9 | 434 |
| HEATR5B | WDR31 | Q8NA23 | 417 |
| HEATR5B | SMIM3 | Q9BZL3 | 412 |
| HEATR5B | TTC17 | Q96AE7 | 411 |
| HEATR5B | SCFD1 | Q8WVM8 | 411 |
| HEATR5B | PLEKHH3 | Q7Z736 | 398 |
| HEATR5B | ACP7 | Q6ZNF0 | 382 |
| HEATR5B | SNTN | A6NMZ2 | 380 |
| HEATR5B | AFTPH | Q6ULP2 | 370 |
| HEATR5B | TTC23 | Q5W5X9 | 369 |
| HEATR5B | SCYL2 | Q6P3W7 | 367 |
| HEATR5B | WDR70 | Q9NW82 | 363 |
IntAct
36 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PTPN3 | YWHAQ | psi-mi:“MI:2364”(proximity) | 0.850 |
| VAPB | FAM83G | psi-mi:“MI:0914”(association) | 0.730 |
| PTPN3 | MCC | psi-mi:“MI:0914”(association) | 0.660 |
| AP1S2 | AP1G1 | psi-mi:“MI:0914”(association) | 0.660 |
| VAPA | FAM83G | psi-mi:“MI:0914”(association) | 0.640 |
| ANKRD22 | ESYT2 | psi-mi:“MI:0914”(association) | 0.530 |
| MLF1 | NDC80 | psi-mi:“MI:0914”(association) | 0.530 |
| AURKA | WDR62 | psi-mi:“MI:0914”(association) | 0.530 |
| SCRIB | HEATR5B | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| DLG1 | HEATR5B | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| AP1S2 | SLC43A3 | psi-mi:“MI:0914”(association) | 0.350 |
| Xpo1 | IFT56 | psi-mi:“MI:0914”(association) | 0.350 |
| APBB1 | SSPOP | psi-mi:“MI:0914”(association) | 0.350 |
| ESR1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| CLTA | CLTB | psi-mi:“MI:0914”(association) | 0.350 |
| GPR17 | TMEM120B | psi-mi:“MI:0914”(association) | 0.350 |
| EFNA4 | NBAS | psi-mi:“MI:0914”(association) | 0.350 |
| RAB43 | TRAPPC13 | psi-mi:“MI:0914”(association) | 0.350 |
| NPTN | RTL8C | psi-mi:“MI:0914”(association) | 0.350 |
| AP1B1 | SYNJ1 | psi-mi:“MI:0914”(association) | 0.350 |
| AP1S3 | AP1G1 | psi-mi:“MI:0914”(association) | 0.350 |
| AP1M2 | AP1G1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (80): HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Affinity Capture-MS), HEATR5B (Proximity Label-MS)
ESM2 similar proteins: A0JP94, A1A5F2, A1EC95, A2BID5, A9JRI0, E7FAW3, E7FBU4, E9PVA8, F4HRS2, F4IP13, K8ERU3, O35095, O43299, P42695, P49815, P49816, Q08CY4, Q0DJS1, Q28205, Q2KJ97, Q3U829, Q3UHQ6, Q5JWR5, Q5PRF0, Q5R5R2, Q5SPP5, Q5ZIG0, Q61037, Q640K1, Q642P2, Q68F70, Q6AI08, Q6GN08, Q6GPP1, Q6P1G0, Q6ZNJ1, Q6ZQA0, Q6ZQK0, Q7T006, Q7ZY56
Diamond homologs: A0JP94, A1A5F2, Q5PRF0, Q86XA9, Q8C547, Q8JFV4, Q9P2D3, P39526
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 38 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | 5 | 113.3× | 2e-08 |
| The role of Nef in HIV-1 replication and disease pathogenesis | 5 | 113.3× | 2e-08 |
| Lysosome Vesicle Biogenesis | 7 | 81.6× | 3e-10 |
| Host Interactions of HIV factors | 5 | 60.0× | 5e-07 |
| trans-Golgi Network Vesicle Budding | 5 | 45.3× | 2e-06 |
| Golgi Associated Vesicle Biogenesis | 6 | 42.9× | 1e-07 |
| HIV Infection | 5 | 21.2× | 5e-05 |
| MHC class II antigen presentation | 6 | 19.1× | 1e-05 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| synaptic vesicle endocytosis | 5 | 65.5× | 3e-06 |
| intracellular protein transport | 8 | 15.7× | 4e-06 |
| vesicle-mediated transport | 5 | 14.6× | 7e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
295 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 3 |
| Uncertain significance | 244 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (3)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2429105 | NM_019024.3(HEATR5B):c.1615C>T (p.Arg539Ter) | Likely pathogenic |
| 992892 | NM_019024.3(HEATR5B):c.5051-1G>A | Likely pathogenic |
| 992893 | NM_019024.3(HEATR5B):c.5050+4A>G | Likely pathogenic |
SpliceAI
6366 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:36981792:CTC:C | acceptor_gain | 1.0000 |
| 2:36981793:TC:T | acceptor_gain | 1.0000 |
| 2:36981794:CC:C | acceptor_gain | 1.0000 |
| 2:36981795:C:CC | acceptor_gain | 1.0000 |
| 2:36988638:ATACT:A | donor_loss | 1.0000 |
| 2:36988639:TACTT:T | donor_loss | 1.0000 |
| 2:36988640:ACTT:A | donor_loss | 1.0000 |
| 2:36988641:CT:C | donor_loss | 1.0000 |
| 2:36988642:TTACT:T | donor_loss | 1.0000 |
| 2:36988643:TA:T | donor_loss | 1.0000 |
| 2:36988644:A:AC | donor_gain | 1.0000 |
| 2:36988644:ACT:A | donor_loss | 1.0000 |
| 2:36988645:C:CA | donor_gain | 1.0000 |
| 2:36988645:C:G | donor_loss | 1.0000 |
| 2:36988645:CT:C | donor_gain | 1.0000 |
| 2:36988645:CTG:C | donor_gain | 1.0000 |
| 2:36988645:CTGT:C | donor_gain | 1.0000 |
| 2:36988645:CTGTT:C | donor_gain | 1.0000 |
| 2:37000580:GGTTA:G | donor_loss | 1.0000 |
| 2:37000581:GTTA:G | donor_loss | 1.0000 |
| 2:37000582:TTACC:T | donor_loss | 1.0000 |
| 2:37000583:TACCT:T | donor_loss | 1.0000 |
| 2:37000584:A:AT | donor_loss | 1.0000 |
| 2:37000585:C:A | donor_loss | 1.0000 |
| 2:37000810:CATC:C | acceptor_gain | 1.0000 |
| 2:37002347:A:C | donor_gain | 1.0000 |
| 2:37002374:T:A | donor_gain | 1.0000 |
| 2:37003540:A:AC | donor_gain | 1.0000 |
| 2:37003541:C:CG | donor_gain | 1.0000 |
| 2:37003545:G:C | donor_gain | 1.0000 |
AlphaMissense
13395 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:37008665:C:G | D1490H | 1.000 |
| 2:37008683:A:G | W1484R | 1.000 |
| 2:37008683:A:T | W1484R | 1.000 |
| 2:37013846:C:G | A1427P | 1.000 |
| 2:37013849:A:G | W1426R | 1.000 |
| 2:37013849:A:T | W1426R | 1.000 |
| 2:37013950:A:G | L1392P | 1.000 |
| 2:37013953:A:G | L1391P | 1.000 |
| 2:37013971:A:G | L1385P | 1.000 |
| 2:37014006:C:A | W1373C | 1.000 |
| 2:37014006:C:G | W1373C | 1.000 |
| 2:37014008:A:G | W1373R | 1.000 |
| 2:37014008:A:T | W1373R | 1.000 |
| 2:37019851:A:C | F1354L | 1.000 |
| 2:37019851:A:T | F1354L | 1.000 |
| 2:37019853:A:G | F1354L | 1.000 |
| 2:37019864:A:G | L1350P | 1.000 |
| 2:37019867:G:T | A1349D | 1.000 |
| 2:37020674:A:G | L1339P | 1.000 |
| 2:37020691:A:C | F1333L | 1.000 |
| 2:37020691:A:T | F1333L | 1.000 |
| 2:37020693:A:G | F1333L | 1.000 |
| 2:37020737:A:G | L1318P | 1.000 |
| 2:37020746:A:G | L1315P | 1.000 |
| 2:37020749:C:T | G1314E | 1.000 |
| 2:37020750:C:A | G1314W | 1.000 |
| 2:37020750:C:G | G1314R | 1.000 |
| 2:37020750:C:T | G1314R | 1.000 |
| 2:37020790:G:C | F1300L | 1.000 |
| 2:37020790:G:T | F1300L | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000041110 (2:37009492 G>A), RS1000046415 (2:36984584 A>G), RS1000061893 (2:37037330 A>G), RS1000151344 (2:37083994 A>C,G), RS1000175946 (2:36999728 C>T), RS1000217757 (2:37004545 T>C), RS1000231200 (2:37078772 C>T), RS1000241044 (2:37005520 A>G), RS1000244742 (2:37040908 A>G), RS1000262246 (2:37078465 T>A), RS1000309890 (2:36993602 T>C), RS1000313954 (2:37051106 C>T), RS1000330881 (2:36994728 A>C), RS1000346874 (2:37034848 G>A), RS1000372322 (2:37072449 A>G)
Disease associations
OMIM: gene MIM:619627 | disease phenotypes: MIM:618501
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| pontocerebellar hypoplasia | Moderate | Autosomal recessive |
Mondo (2): cerebellar atrophy with seizures and variable developmental delay (MONDO:0032788), pontocerebellar hypoplasia (MONDO:0020135)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
12 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007103_4 | QRS duration | 1.000000e-08 |
| GCST007104_4 | QRS duration | 1.000000e-13 |
| GCST007267_282 | Systolic blood pressure | 6.000000e-09 |
| GCST008163_2 | Height | 4.000000e-06 |
| GCST008972_261 | Urate levels | 4.000000e-08 |
| GCST010697_37 | Cortical surface area (min-P) | 6.000000e-31 |
| GCST010698_20 | Subcortical volume (min-P) | 1.000000e-08 |
| GCST010699_106 | Brain morphology (min-P) | 2.000000e-11 |
| GCST010700_34 | Cortical thickness (MOSTest) | 2.000000e-08 |
| GCST010701_57 | Cortical surface area (MOSTest) | 4.000000e-16 |
| GCST010702_109 | Subcortical volume (MOSTest) | 1.000000e-09 |
| GCST010703_96 | Brain morphology (MOSTest) | 6.000000e-46 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006335 | systolic blood pressure |
| EFO:0004531 | urate measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0004840 | cortical thickness |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C580383 | Pontocerebellar Hypoplasia (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression | 2 |
| FR900359 | decreases phosphorylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases expression | 1 |
| tetrabromobisphenol A | decreases expression | 1 |
| manganese chloride | decreases expression, increases abundance | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| nickel sulfate | decreases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| K 7174 | increases expression | 1 |
| ICG 001 | decreases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| pentabrominated diphenyl ether 100 | decreases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | decreases expression | 1 |
| Arsenic Trioxide | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Dinitrochlorobenzene | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Eugenol | decreases expression | 1 |
| Hydralazine | affects cotreatment, decreases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Manganese | increases abundance, decreases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Urethane | increases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation, increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: pontocerebellar hypoplasia
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): cerebellar atrophy with seizures and variable developmental delay, pontocerebellar hypoplasia